Revenue recognition

3 Months Ended

Apr. 02, 2022

Revenue from Contract with Customer [Abstract]

Revenue recognition

Revenue recognition

Our policies for recognizing sales have not changed from those described in the Company’s 2021 Annual Report on Form 10-K. The Company attributes net sales to external customers to the U.S. and to all foreign countries based on the legal entity from which the sale originated. The following table presents our net sales by segment disaggregated by geographic markets and major products (Vertical) as follows:

	Three Months Ended
	April 2, 2022		April 3, 2021
Primary geographic markets:
U.S.	$	104,081	$	74,538
International	13,209		7,240
Total net sales	$	117,290	$	81,778
Vertical:
Pain Treatments	$	52,053	$	41,530
Restorative Therapies	34,360		21,821
Surgical Solutions	30,877		18,427
Total net sales	$	117,290	$	81,778